We use cookies for a better user experience. Read our Privacy Policy

I Agree

Seasonal Affective Disorder (SAD) Market

Seasonal Affective Disorder (SAD) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Seasonal Affective Disorder (SAD) Market: Introduction

  • Seasonal affective disorder (SAD) is a type of depression that occurs during a certain season of the year. This disorder is related to fluctuation in seasons; especially occurs in winter, but some people could have it during summer. Seasonal affective disorder is most prevalent in women, people between the ages of 15 to 55, and people who live far from the equator where winter daylight hours are too short. Common symptoms of SAD are hopelessness, increased appetite, weight gain, loss of ability to concentrate, and social withdrawal, among others. Risk factors associated with this disorder are depressive disorders such as bipolar II disorder, bipolar I disorder, and others.
  • The global seasonal affective disorder (SAD) market can be segmented based on type, end-user, treatment, test type, and region. In terms of type, the global market can be classified into fall & winter, spring & summer, and others. Based on test type, the global seasonal affective disorder market can be categorized into psychological evaluation, lab tests, and others. The lab tests segment can be split into thyroid blood test, CBC, and others. The psychological evaluation segment can be segregated into personality tests, intelligence tests, attitude tests, achievement tests, neuropsychological tests, aptitude tests, vocational tests, direct observation tests, and others. In terms of treatment, the global seasonal affective disorder market can be divided into light therapy, psychotherapy, medications, counselling, and others. The medications segment can be bifurcated into antidepressants and others. The antidepressants sub-segment can be split into reuptake inhibitors (SSRIs) and others. The psychotherapy segment can be categorized into attachment-based psychotherapy, art therapy, behavioral therapy, cognitive analytical therapy (CAT), body psychotherapy, existential psychotherapy, gestalt therapy, and others. Based on end-user, the global market can be divided into clinics, hospitals, research institutes, and others.

Key Drivers, Restraints, and Opportunities of Global Seasonal Affective Disorder (SAD) Market

  • A range of drugs and devices for treatment of seasonal affective disorder treatment are available in the market. Light therapy is utilized as the first line of therapy for seasonal affective disorder. Devices including light boxes, dawn stimulators, desk lamps, and sun visors are available in the market as light therapy for seasonal affective disorder.
  • Both branded and generic drugs for seasonal affective disorder treatment are available in developed and emerging economies. Citalopram and Buproban are the most commonly used drugs for seasonal affective disorder. A number of generic options for Citalopram and Buproban are also available in the market. Therefore, easy availability of seasonal affective disorder therapeutics is projected to drive the global market.
  • Experts have indicated that improper seasonal affective disorder therapeutics could have severe side effects. Dosage should be reduced in order to prevent these side effects. Adjunctive light therapy should begin with a dose titration of 7,000 lux, 4000 K blue enriched broad-spectrum white light for 15 minutes per day at midday around 2.30 pm. Then 15 minutes should be added each week until the dosage reaches a range of 45 minutes to 60 minutes per day. Average time to response and remission varies between four and six weeks. Continuous patient-physician engagement leads to better seasonal affective disorder treatment outcomes.

North America to Capture Major Share of Global Seasonal Affective Disorder (SAD) Market

  • North America is projected to dominate the global market in terms of share during the forecast period owing to rise in prevalence of seasonal depression. Around 5% of the population of the U.S. suffers from seasonal affective disorder. This is attributed to changing lifestyles and increase in awareness about seasonal depression and its treatment.
  • Asia Pacific has less prevalence of seasonal affective disorder. Rise in awareness, increase in the geriatric population, and surge in medical tourism in emerging economies such as China and India are expected to boost the growth of the market in the region.

Key Players Operating in Global Seasonal Affective Disorder (SAD) Market

The global seasonal affective disorder (SAD) market is highly fragmented due to the presence of large number of key players. These players hold a major share in their respective regions. Leading players operating in the global seasonal affective disorder (SAD) market are:

  • Allergan plc
  • Eli Lily Company
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Teva Pharmaceuticals, Inc.
  • Bausch Health Companies, Inc.
  • F. Hoffmann-La Roche AG
  • Mylan N.V.
  • Sanofi AG
  • Novartis AG
  • Janssen Pharmaceuticals, Inc.
  • The Sunbox Company
  • Verilux, Inc.
  • Carex Health
  • Northern Light Technologies
  • Beurer GmbH
  • Koninklijke Philips N.V.
  • Others

Global Seasonal Affective Disorder (SAD) Market: Research Scope

Global Seasonal Affective Disorder (SAD) Market, by Type

  • Fall & Winter
  • Spring & Summer
  • Others

Global Seasonal Affective Disorder (SAD) Market, by End-user

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Test Type

  • Lab Tests
    • CBC
    • Thyroid Blood Test
    • Others
  • Psychological Evaluation
    • Intelligence Test
    • Personality Test
    • Attitude Test
    • Achievement Test
    • Aptitude Test
    • Neuropsychological Test
    • Vocational Test
    • Direct Observation Test
    • Others
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Treatment

  • Light Therapy
  • Medications
    • Antidepressants
      • SSRIs
      • Others
    • Others
  • Psychotherapy
    • Art Therapy
    • Attachment-based Psychotherapy
    • Behavioral Therapy
    • Body Psychotherapy
    • Cognitive Analytical Therapy (CAT)
    • Existential Psychotherapy
    • Gestalt Therapy
    • Others
  • Counselling
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes


Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.


Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved